非侵襲的出生前検査の市場規模、シェア&動向分析レポート:妊娠期間別、妊娠リスク別、方法別、技術別、製品別、用途別、最終用途別、地域別、セグメント別予測、2022年~2030年Non Invasive Prenatal Testing Market Size, Share & Trends Analysis Report By Gestation Period, By Pregnancy Risk, By Method, By Technology, By Product, By Application, By End-use, By Region, And Segment Forecasts, 2022 - 2030 非侵襲的出生前検査市場の成長とトレンド Grand View Research, Inc.の新しいレポートによると、世界の非侵襲的出生前検査の市場規模は2030年までに77億1000万米ドルに達し、2022年から2030年までCAGR9.61%で... もっと見る
日本語のページは自動翻訳を利用し作成しています。
サマリー非侵襲的出生前検査市場の成長とトレンドGrand View Research, Inc.の新しいレポートによると、世界の非侵襲的出生前検査の市場規模は2030年までに77億1000万米ドルに達し、2022年から2030年までCAGR9.61%で拡大すると予測されています。染色体異常の発生率の増加が、市場の成長を加速させると予想されます。中でも、年間出生数が1465万人近くに上り、高リスクの妊娠が増加している中国では、非侵襲的な出生前スクリーニングに大きな機会があると考えられています。 また、インドでは遺伝性疾患の負担が大きくなっています。様々な研究により、同国では新生児166人に1人の頻度で染色体異常が見つかっており、21トリソミー(ダウン症)は出生800人に1人と高い発生率を示し、毎年3万2千人のダウン症の新生児が誕生していることが報告されています。NIPTを用いた正確かつ早期のスクリーニングにより、赤ちゃんの遺伝的問題を知ることは、家族にとって有益なことです。したがって、この高い発生率は出生前検査の需要を押し上げると予想されます。 COVID-19によるロックダウンを受けて、NIPTは、絨毛膜絨毛サンプリングや羊水穿刺などの侵襲的な処置に比べ、感染リスクを最小限に抑えながら高精度のスクリーニングを実現するため、注目を集めました。さらに、NIPTの処方に対する需要が高まりましたが、ほとんどの国ではインフラが整っていないことや遠隔医療施設の採用により、対象となる人は限られていました。 非侵襲的出生前検査に関する保険償還のシナリオは非常に多様である。しかし、政府からの支援と有利な保険政策が市場の成長を後押ししています。例えば、オランダでは、出生前検査の費用は第2トリメスターで完全に払い戻され、これらのテストの採用が増加しました。インドや中国などの新興国におけるバイオおよび製薬業界を奨励する政府のイニシアティブの増加は、非侵襲的な出生前検査ソリューションおよびサービスの需要を高めると予想されます。 市場の主要企業は、製品ポートフォリオを強化し、顧客に革新的な製品を提供するために、新製品開発に注力しています。2020年3月、アジレント・テクノロジーは、細胞遺伝学研究所による出生前および出生後の研究をサポートする3つの新しいマイクロアレイを発売しました。サイトウ・マイクロアレイのプローブは、体質DNAサンプルにおける神経精神疾患、発達遅延、知的障害、先天異常などに関連するコピー数変異やコピーニュートラルヘテロ接合性消失の高分解能検出を実現します。 非侵襲性出生前検査市場レポートハイライト - 妊娠期間別では、妊娠第2期に実施される非侵襲的出生前処置の数が最も多いことから、2021年には13-24週が市場を支配した - 妊娠リスクの低いセグメントは、予測期間中に大きな成長を遂げると予想されます。平均的なリスクの妊娠に対する予算割り当てなど、政府からのサポートがセグメントの成長に寄与した - 製品別では、母体血漿検査における無細胞DNAのセグメントが2021年に最大の収益シェアを占めました。無細胞DNAは、様々な遺伝子分析を通じて、出生前ケアにおける遺伝性疾患のリスク予測に活用されるようになってきている - 予測期間中、アジア太平洋地域が最も高いCAGRを示すと予想されます。妊産婦年齢の上昇と医療インフラの整備が市場成長を強化する可能性が高い - 研究開発投資の多さ、高度な医療施設の存在、全ゲノムシーケンスの発達により、2021年には北米が市場を支配した 目次Table of ContentsChapter 1 Methodology and Scope 1.1 Market Segmentation and Scope 1.1.1 Segment Scope 1.1.2 Regional Scope 1.1.3 Estimates And Forecast Timeline 1.2 Research Methodology 1.3 Information Procurement 1.3.1 Purchased Database 1.3.2 Gvr’s Internal Database 1.3.3 Secondary Sources 1.3.4 Primary Research 1.3.5 Details Of Primary Research 1.4 Information or Data Analysis 1.4.1 Data Analysis Models 1.5 Market Formulation & Validation 1.6 Model Details 1.6.1 Commodity Flow Analysis 1.6.1.1 Approach: Commodity Flow Approach 1.7 List of Secondary Sources 1.8 List of Abbreviations 1.9 Objectives 1.9.1 Objective 1 1.9.2 Objective 2 1.9.3 Objective 3 1.9.4 Objective 4 Chapter 2 Executive Summary 2.1 Market Summary Chapter 3 Non-Invasive Prenatal Testing Market Variables, Trends, and Scope 3.1 Penetration and Growth Prospect Mapping for Gestation Period 3.1.1 Consumer Behavior Analysis 3.2 Regulatory Framework 3.3 Market Driver Analysis 3.3.1 Increasing Average Maternal Age And Rising Incidence Of Chromosomal Syndromes 3.3.2 High Demand For Early And Noninvasive Fetal Testing Procedure 3.3.3 Improvements In The Reimbursement Scenario 3.3.4 Rising Collaborations And Licensing Agreements 3.4 Market Restraint Analysis 3.4.1 Ethical Concerns With Respect To Reproductive Genetics 3.4.2 Reliability Of Test Results 3.4.3 Pricing Analysis 3.5 SWOT Analysis, by Factor (Political & Legal, Economic, and Technological) 3.6 Porter’s Five Forces Analysis 3.7 COVID-19 Impact Analysis Chapter 4 Non-Invasive Prenatal Testing Market - Segment Analysis, by Gestation Period, 2018 - 2030 (USD Million) 4.1 Non-Invasive Prenatal Testing Market: Gestation Period Movement Analysis 4.2 0-12 Weeks 4.2.1 0-12 Weeks Market Estimates And Forecast, 2018 - 2030 (USD Million) 4.3 13-24 Weeks 4.3.1 13-24 Weeks Market Estimates And Forecast, 2018 - 2030 (USD Million) 4.4 25-36 Weeks 4.4.1 25-36 Weeks Market Estimates And Forecast, 2018 - 2030 (USD Million) Chapter 5 Non-Invasive Prenatal Testing Market - Segment Analysis, by Pregnancy Risk, 2018 - 2030 (USD Million) 5.1 Non-Invasive Prenatal Testing Market: Pregnancy Risk Movement Analysis 5.2 High & Average Risk Pregnancy Testing 5.2.1 High & Average Risk Pregnancy Market Estimates And Forecast, 2018 - 2030 (USD Million) 5.3 Low-Risk Pregnancy Testing 5.3.1 Low-Risk Pregnancy Market Estimates And Forecast, 2018 - 2030 (USD Million) Chapter 6 Non-Invasive Prenatal Testing Market - Segment Analysis, by Method, 2018 - 2030 (USD Million) 6.1 Non-Invasive Prenatal Testing Market: Method Movement Analysis 6.2 Ultrasound Detection 6.2.1 Ultrasound Detection Market Estimates And Forecast, 2018 - 2030 (USD Million) 6.3 Biochemical Screening Tests 6.3.1 Biochemical Screening Tests Market Estimates And Forecast, 2018 - 2030 (USD Million) 6.4 Cell-Free Dna In Maternal Plasma Tests 6.4.1 Cell-Free Dna In Maternal Plasma Tests Market Estimates And Forecast, 2018 - 2030 (USD Million) Chapter 7 Non-Invasive Prenatal Testing Market - Segment Analysis, by Technology, 2018 - 2030 (USD Million) 7.1 Non-Invasive Prenatal Testing Market: Technology Movement Analysis 7.2 Next-Generation Sequencing 7.2.1 Next-Generation Sequencing Market Estimates And Forecast, 2018 - 2030 (USD Million) 7.3 Array Technology 7.3.1 Array Technology Market Estimates And Forecast, 2018 - 2030 (USD Million) 7.4 Polymerase Chain Reaction (Pcr) 7.4.1 Polymerase Chain Reaction (Pcr) Market Estimates And Forecast, 2018 - 2030 (USD Million) 7.5 Other Technologies 7.5.1 Other Technologies Market Estimates And Forecast, 2018 - 2030 (USD Million) Chapter 8 Non-Invasive Prenatal Testing Market - Segment Analysis, by Product, 2018 - 2030 (USD Million) 8.1 Non-Invasive Prenatal Testing Market: Product Movement Analysis 8.2 Consumables and Reagents 8.2.1 Consumables And Reagents Market Estimates And Forecast, 2018 - 2030 (USD Million) 8.3 Instruments 8.3.1 Instruments Market Estimates And Forecast, 2018 - 2030 (USD Million) Chapter 9 Non-Invasive Prenatal Testing Market - Segment Analysis, by End-Use, 2018 - 2030 (USD Million) 9.1 Non-Invasive Prenatal Testing Market: End-use Movement Analysis 9.2 Hospitals 9.2.1 Hospitals Market Estimates And Forecast, 2018 - 2030 (USD Million) 9.3 Diagnostic Laboratories 9.3.1 Diagnostic Laboratories Market Estimates And Forecast, 2018 - 2030 (USD Million) Chapter 10 Non-Invasive Prenatal Testing Market - Segment Analysis, by Application, 2018 - 2030 (USD Million) 10.1 Non-Invasive Prenatal Testing Market: Application Movement Analysis 10.2 Trisomy 10.2.1 Trisomy Market Estimates And Forecast, 2018 - 2030 (USD Million) 10.3 Microdeletion Syndrome 10.3.1 Microdeletion Syndrome Market Estimates And Forecast, 2018 - 2030 (USD Million) 10.4 Other Applications 10.4.1 Other Applications Market Estimates And Forecast, 2018 - 2030 (USD Million) Chapter 11 Non-Invasive Prenatal Testing Market - Segment Analysis, by Region, 2018 - 2030 (USD Million) 11.1 Non-Invasive Prenatal Testing Market: Regional Movement Analysis 11.2 North America 11.2.1 North America Market Estimates And Forecast, 2018 - 2030 (USD Million) 11.2.2 U.S. 11.2.2.1 U.S. Market Estimates And Forecast, 2018 - 2030 (USD Million) 11.2.3 Canada 11.2.3.1 Canada Market Estimates And Forecast, 2018 - 2030 (USD Million) 11.3 Europe 11.3.1 Europe Market Estimates And Forecast, 2018 - 2030 (USD Million) 11.3.2 Germany 11.3.2.1 Germany Market Estimates And Forecast, 2018 - 2030 (USD Million) 11.3.3 U.K. 11.3.3.1 U.K. Market Estimates And Forecast, 2018 - 2030 (USD Million) 11.3.4 France 11.3.4.1 France Market Estimates And Forecast, 2018 - 2030 (USD Million) 11.3.5 Italy 11.3.5.1 Italy Market Estimates And Forecast, 2018 - 2030 (USD Million) 11.3.6 Spain 11.3.6.1 Spain Market Estimates And Forecast, 2018 - 2030 (USD Million) 11.4 Asia Pacific 11.4.1 Asia Pacific Market Estimates And Forecast, 2018 - 2030 (USD Million) 11.4.2 Japan 11.4.2.1 Japan Market Estimates And Forecast, 2018 - 2030 (USD Million) 11.4.3 China 11.4.3.1 China Market Estimates And Forecast, 2018 - 2030 (USD Million) 11.4.4 India 11.4.4.1 India Market Estimates And Forecast, 2018 - 2030 (USD Million) 11.4.5 Singapore 11.4.5.1 Singapore Market Estimates And Forecast, 2018 - 2030 (USD Million) 11.4.6 Australia 11.4.6.1 Australia Market Estimates And Forecast, 2018 - 2030 (USD Million) 11.5 Latin America 11.5.1 Latin America Market Estimates And Forecast, 2018 - 2030 (USD Million) 11.5.2 Brazil 11.5.2.1 Brazil Market Estimates And Forecast, 2018 - 2030 (USD Million) 11.5.3 Mexico 11.5.3.1 Mexico Market Estimates And Forecast, 2018 - 2030 (USD Million) 11.6 MEA 11.6.1 MEA Market Estimates And Forecast, 2018 - 2030 (USD Million) 11.6.2 South Africa 11.6.2.1 South Africa market estimates and forecast, 2018 - 2030 (USD Million) 11.6.3 Saudi Arabia 11.6.3.1 Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million) Chapter 12 Non-Invasive Prenatal Testing Market - Competitive Analysis 12.1 Recent Developments & Impact Analysis, by Key Market Participants 12.1.1 Ansoff Matrix 12.2 Company Categorization 12.2.1 Innovators 12.2.2 Market Leaders 12.2.3 Key Company Market Share Analysis, 2021 12.3 Vendor Landscape 12.3.1 List Of Key Distributors And Channel Partners 12.3.2 Key Customers 12.3.3 List Of Key Emerging Companies 12.4 Synergy Analysis: Major Deals & Strategic Alliances 12.4.1 New Product Launch 12.4.2 Acquisitions 12.4.3 Expansion 12.4.4 Partnerships 12.5 Company Profiles 12.5.1 NATERA INC. 12.5.1.1 Company overview 12.5.1.2 Financial performance 12.5.1.3 Product benchmarking 12.5.1.4 Strategic initiatives 12.5.2 CENTOGENE N.V. 12.5.2.1 Company overview 12.5.2.2 Financial performance 12.5.2.3 Product benchmarking 12.5.2.4 Strategic initiatives 12.5.3 ILLUMINA INC (VERINATA HEALTH INC.) 12.5.3.1 Company overview 12.5.3.2 Financial performance 12.5.3.3 Product benchmarking 12.5.3.4 Strategic initiatives 12.5.4 EUROFINS LIFECODEXX GMBH 12.5.4.1 Company overview 12.5.4.2 LifeCodexx AG 12.5.4.3 Financial performance 12.5.4.4 Product benchmarking 12.5.4.5 Strategic initiatives 12.5.5 MEDGENOME 12.5.5.1 Company overview 12.5.5.2 Product benchmarking 12.5.5.3 Strategic initiatives 12.5.6 ARIOSA DIAGNOSTICS (F. HOFFMANN-LA ROCHE LTD.) 12.5.6.1 Company overview 12.5.6.2 Financial performance 12.5.6.3 Product benchmarking 12.5.6.4 Strategic initiatives 12.5.7 MYRIAD WOMEN'S HEALTH, INC. (COUNSYL, INC.) 12.5.7.1 Company overview 12.5.7.2 Financial performance 12.5.7.3 Product benchmarking 12.5.7.4 Strategic initiatives 12.5.8 PROGENITY, INC. 12.5.8.1 Company overview 12.5.8.2 Product benchmarking 12.5.8.3 Strategic initiatives 12.5.9 QIAGEN 12.5.9.1 Company overview 12.5.9.2 Financial performance 12.5.9.3 Product benchmarking 12.5.9.4 Strategic initiatives 12.5.10 LABORATORY CORPORATION OF AMERICA HOLDINGS 12.5.10.1 Company overview 12.5.10.2 Sequenom 12.5.10.3 Integrated Genomics, Inc. 12.5.10.4 Financial performance 12.5.10.5 Product benchmarking 12.5.10.6 Strategic initiatives 12.5.11 QUEST DIAGNOSTICS INCORPORATED 12.5.11.1 Company overview 12.5.11.2 Financial performance 12.5.11.3 Product benchmarking 12.5.11.4 Strategic initiatives
SummaryNon Invasive Prenatal Testing Market Growth & Trends Table of ContentsTable of ContentsChapter 1 Methodology and Scope 1.1 Market Segmentation and Scope 1.1.1 Segment Scope 1.1.2 Regional Scope 1.1.3 Estimates And Forecast Timeline 1.2 Research Methodology 1.3 Information Procurement 1.3.1 Purchased Database 1.3.2 Gvr’s Internal Database 1.3.3 Secondary Sources 1.3.4 Primary Research 1.3.5 Details Of Primary Research 1.4 Information or Data Analysis 1.4.1 Data Analysis Models 1.5 Market Formulation & Validation 1.6 Model Details 1.6.1 Commodity Flow Analysis 1.6.1.1 Approach: Commodity Flow Approach 1.7 List of Secondary Sources 1.8 List of Abbreviations 1.9 Objectives 1.9.1 Objective 1 1.9.2 Objective 2 1.9.3 Objective 3 1.9.4 Objective 4 Chapter 2 Executive Summary 2.1 Market Summary Chapter 3 Non-Invasive Prenatal Testing Market Variables, Trends, and Scope 3.1 Penetration and Growth Prospect Mapping for Gestation Period 3.1.1 Consumer Behavior Analysis 3.2 Regulatory Framework 3.3 Market Driver Analysis 3.3.1 Increasing Average Maternal Age And Rising Incidence Of Chromosomal Syndromes 3.3.2 High Demand For Early And Noninvasive Fetal Testing Procedure 3.3.3 Improvements In The Reimbursement Scenario 3.3.4 Rising Collaborations And Licensing Agreements 3.4 Market Restraint Analysis 3.4.1 Ethical Concerns With Respect To Reproductive Genetics 3.4.2 Reliability Of Test Results 3.4.3 Pricing Analysis 3.5 SWOT Analysis, by Factor (Political & Legal, Economic, and Technological) 3.6 Porter’s Five Forces Analysis 3.7 COVID-19 Impact Analysis Chapter 4 Non-Invasive Prenatal Testing Market - Segment Analysis, by Gestation Period, 2018 - 2030 (USD Million) 4.1 Non-Invasive Prenatal Testing Market: Gestation Period Movement Analysis 4.2 0-12 Weeks 4.2.1 0-12 Weeks Market Estimates And Forecast, 2018 - 2030 (USD Million) 4.3 13-24 Weeks 4.3.1 13-24 Weeks Market Estimates And Forecast, 2018 - 2030 (USD Million) 4.4 25-36 Weeks 4.4.1 25-36 Weeks Market Estimates And Forecast, 2018 - 2030 (USD Million) Chapter 5 Non-Invasive Prenatal Testing Market - Segment Analysis, by Pregnancy Risk, 2018 - 2030 (USD Million) 5.1 Non-Invasive Prenatal Testing Market: Pregnancy Risk Movement Analysis 5.2 High & Average Risk Pregnancy Testing 5.2.1 High & Average Risk Pregnancy Market Estimates And Forecast, 2018 - 2030 (USD Million) 5.3 Low-Risk Pregnancy Testing 5.3.1 Low-Risk Pregnancy Market Estimates And Forecast, 2018 - 2030 (USD Million) Chapter 6 Non-Invasive Prenatal Testing Market - Segment Analysis, by Method, 2018 - 2030 (USD Million) 6.1 Non-Invasive Prenatal Testing Market: Method Movement Analysis 6.2 Ultrasound Detection 6.2.1 Ultrasound Detection Market Estimates And Forecast, 2018 - 2030 (USD Million) 6.3 Biochemical Screening Tests 6.3.1 Biochemical Screening Tests Market Estimates And Forecast, 2018 - 2030 (USD Million) 6.4 Cell-Free Dna In Maternal Plasma Tests 6.4.1 Cell-Free Dna In Maternal Plasma Tests Market Estimates And Forecast, 2018 - 2030 (USD Million) Chapter 7 Non-Invasive Prenatal Testing Market - Segment Analysis, by Technology, 2018 - 2030 (USD Million) 7.1 Non-Invasive Prenatal Testing Market: Technology Movement Analysis 7.2 Next-Generation Sequencing 7.2.1 Next-Generation Sequencing Market Estimates And Forecast, 2018 - 2030 (USD Million) 7.3 Array Technology 7.3.1 Array Technology Market Estimates And Forecast, 2018 - 2030 (USD Million) 7.4 Polymerase Chain Reaction (Pcr) 7.4.1 Polymerase Chain Reaction (Pcr) Market Estimates And Forecast, 2018 - 2030 (USD Million) 7.5 Other Technologies 7.5.1 Other Technologies Market Estimates And Forecast, 2018 - 2030 (USD Million) Chapter 8 Non-Invasive Prenatal Testing Market - Segment Analysis, by Product, 2018 - 2030 (USD Million) 8.1 Non-Invasive Prenatal Testing Market: Product Movement Analysis 8.2 Consumables and Reagents 8.2.1 Consumables And Reagents Market Estimates And Forecast, 2018 - 2030 (USD Million) 8.3 Instruments 8.3.1 Instruments Market Estimates And Forecast, 2018 - 2030 (USD Million) Chapter 9 Non-Invasive Prenatal Testing Market - Segment Analysis, by End-Use, 2018 - 2030 (USD Million) 9.1 Non-Invasive Prenatal Testing Market: End-use Movement Analysis 9.2 Hospitals 9.2.1 Hospitals Market Estimates And Forecast, 2018 - 2030 (USD Million) 9.3 Diagnostic Laboratories 9.3.1 Diagnostic Laboratories Market Estimates And Forecast, 2018 - 2030 (USD Million) Chapter 10 Non-Invasive Prenatal Testing Market - Segment Analysis, by Application, 2018 - 2030 (USD Million) 10.1 Non-Invasive Prenatal Testing Market: Application Movement Analysis 10.2 Trisomy 10.2.1 Trisomy Market Estimates And Forecast, 2018 - 2030 (USD Million) 10.3 Microdeletion Syndrome 10.3.1 Microdeletion Syndrome Market Estimates And Forecast, 2018 - 2030 (USD Million) 10.4 Other Applications 10.4.1 Other Applications Market Estimates And Forecast, 2018 - 2030 (USD Million) Chapter 11 Non-Invasive Prenatal Testing Market - Segment Analysis, by Region, 2018 - 2030 (USD Million) 11.1 Non-Invasive Prenatal Testing Market: Regional Movement Analysis 11.2 North America 11.2.1 North America Market Estimates And Forecast, 2018 - 2030 (USD Million) 11.2.2 U.S. 11.2.2.1 U.S. Market Estimates And Forecast, 2018 - 2030 (USD Million) 11.2.3 Canada 11.2.3.1 Canada Market Estimates And Forecast, 2018 - 2030 (USD Million) 11.3 Europe 11.3.1 Europe Market Estimates And Forecast, 2018 - 2030 (USD Million) 11.3.2 Germany 11.3.2.1 Germany Market Estimates And Forecast, 2018 - 2030 (USD Million) 11.3.3 U.K. 11.3.3.1 U.K. Market Estimates And Forecast, 2018 - 2030 (USD Million) 11.3.4 France 11.3.4.1 France Market Estimates And Forecast, 2018 - 2030 (USD Million) 11.3.5 Italy 11.3.5.1 Italy Market Estimates And Forecast, 2018 - 2030 (USD Million) 11.3.6 Spain 11.3.6.1 Spain Market Estimates And Forecast, 2018 - 2030 (USD Million) 11.4 Asia Pacific 11.4.1 Asia Pacific Market Estimates And Forecast, 2018 - 2030 (USD Million) 11.4.2 Japan 11.4.2.1 Japan Market Estimates And Forecast, 2018 - 2030 (USD Million) 11.4.3 China 11.4.3.1 China Market Estimates And Forecast, 2018 - 2030 (USD Million) 11.4.4 India 11.4.4.1 India Market Estimates And Forecast, 2018 - 2030 (USD Million) 11.4.5 Singapore 11.4.5.1 Singapore Market Estimates And Forecast, 2018 - 2030 (USD Million) 11.4.6 Australia 11.4.6.1 Australia Market Estimates And Forecast, 2018 - 2030 (USD Million) 11.5 Latin America 11.5.1 Latin America Market Estimates And Forecast, 2018 - 2030 (USD Million) 11.5.2 Brazil 11.5.2.1 Brazil Market Estimates And Forecast, 2018 - 2030 (USD Million) 11.5.3 Mexico 11.5.3.1 Mexico Market Estimates And Forecast, 2018 - 2030 (USD Million) 11.6 MEA 11.6.1 MEA Market Estimates And Forecast, 2018 - 2030 (USD Million) 11.6.2 South Africa 11.6.2.1 South Africa market estimates and forecast, 2018 - 2030 (USD Million) 11.6.3 Saudi Arabia 11.6.3.1 Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million) Chapter 12 Non-Invasive Prenatal Testing Market - Competitive Analysis 12.1 Recent Developments & Impact Analysis, by Key Market Participants 12.1.1 Ansoff Matrix 12.2 Company Categorization 12.2.1 Innovators 12.2.2 Market Leaders 12.2.3 Key Company Market Share Analysis, 2021 12.3 Vendor Landscape 12.3.1 List Of Key Distributors And Channel Partners 12.3.2 Key Customers 12.3.3 List Of Key Emerging Companies 12.4 Synergy Analysis: Major Deals & Strategic Alliances 12.4.1 New Product Launch 12.4.2 Acquisitions 12.4.3 Expansion 12.4.4 Partnerships 12.5 Company Profiles 12.5.1 NATERA INC. 12.5.1.1 Company overview 12.5.1.2 Financial performance 12.5.1.3 Product benchmarking 12.5.1.4 Strategic initiatives 12.5.2 CENTOGENE N.V. 12.5.2.1 Company overview 12.5.2.2 Financial performance 12.5.2.3 Product benchmarking 12.5.2.4 Strategic initiatives 12.5.3 ILLUMINA INC (VERINATA HEALTH INC.) 12.5.3.1 Company overview 12.5.3.2 Financial performance 12.5.3.3 Product benchmarking 12.5.3.4 Strategic initiatives 12.5.4 EUROFINS LIFECODEXX GMBH 12.5.4.1 Company overview 12.5.4.2 LifeCodexx AG 12.5.4.3 Financial performance 12.5.4.4 Product benchmarking 12.5.4.5 Strategic initiatives 12.5.5 MEDGENOME 12.5.5.1 Company overview 12.5.5.2 Product benchmarking 12.5.5.3 Strategic initiatives 12.5.6 ARIOSA DIAGNOSTICS (F. HOFFMANN-LA ROCHE LTD.) 12.5.6.1 Company overview 12.5.6.2 Financial performance 12.5.6.3 Product benchmarking 12.5.6.4 Strategic initiatives 12.5.7 MYRIAD WOMEN'S HEALTH, INC. (COUNSYL, INC.) 12.5.7.1 Company overview 12.5.7.2 Financial performance 12.5.7.3 Product benchmarking 12.5.7.4 Strategic initiatives 12.5.8 PROGENITY, INC. 12.5.8.1 Company overview 12.5.8.2 Product benchmarking 12.5.8.3 Strategic initiatives 12.5.9 QIAGEN 12.5.9.1 Company overview 12.5.9.2 Financial performance 12.5.9.3 Product benchmarking 12.5.9.4 Strategic initiatives 12.5.10 LABORATORY CORPORATION OF AMERICA HOLDINGS 12.5.10.1 Company overview 12.5.10.2 Sequenom 12.5.10.3 Integrated Genomics, Inc. 12.5.10.4 Financial performance 12.5.10.5 Product benchmarking 12.5.10.6 Strategic initiatives 12.5.11 QUEST DIAGNOSTICS INCORPORATED 12.5.11.1 Company overview 12.5.11.2 Financial performance 12.5.11.3 Product benchmarking 12.5.11.4 Strategic initiatives
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野の最新刊レポート
Grand View Research社の分野での最新刊レポート
本レポートと同じKEY WORD()の最新刊レポート
よくあるご質問Grand View Research社はどのような調査会社ですか?グランドビューリサーチ(Grand View Research)は通信技術、化学品、材料、ヘルスケア、エネルギーなど広範な市場を対象にした調査報告書を出版しています。 もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/11/14 10:27 156.77 円 166.04 円 201.95 円 |